Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Insulet Corp (NQ: PODD )

292.45 USD +4.55 (+1.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 393,216
Open 286.95
Bid (Size) 255.00 (1)
Ask (Size) 310.00 (1)
Prev. Close 287.90
Today's Range 284.42 - 292.52
52wk Range 213.51 - 309.99
Shares Outstanding 68,873,869
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Insulet to Present at Upcoming Investor Conferences
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at three upcoming... 
From Business Wire News Releases
Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced FDA clearance for use of Eli Lilly and... 
From Business Wire News Releases

Performance

YTD
+16.23%
+16.23%
1 Month
-0.80%
-0.80%
3 Month
+3.86%
+3.86%
6 Month
+8.59%
+8.59%
1 Year
+29.97%
+29.97%

More News

Read More
Insulet Introduces Omnipod DASH® System at Australasian Diabetes Congress
From Business Wire News Releases
Insulet Reports Second Quarter 2021 Revenue Increase of 16% Year-Over-Year
From Business Wire News Releases
Insulet Moves Up In Market Cap Rank, Passing Hologic
Tags Stocks
From Market News Video
5 Top Stocks for September
Tags PUBM PODD SHOP
From Motley Fool
Insulet to Present at Upcoming Investor Conferences
From Business Wire News Releases
Looking into Insulet's Return on Capital Employed
Tags Market News PODD Earnings
From Benzinga
Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021
From Business Wire News Releases
Insulet’s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years
From Business Wire News Releases
Stocks With Rising Relative Price Strength: Insulet
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.